Cargando…
Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines
Respiratory syncytial virus (RSV) is responsible for a significant proportion of global morbidity and mortality affecting young children and older adults. In the aftermath of formalin-inactivated RSV vaccine development, the effort to develop an immunizing agent was carefully guided by epidemiologic...
Autores principales: | Topalidou, Xanthippi, Kalergis, Alexis M., Papazisis, Georgios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609699/ https://www.ncbi.nlm.nih.gov/pubmed/37887775 http://dx.doi.org/10.3390/pathogens12101259 |
Ejemplares similares
-
The road to approved vaccines for respiratory syncytial virus
por: Ruckwardt, Tracy J.
Publicado: (2023) -
Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia—Implications for Vaccine Design
por: Rey-Jurado, Emma, et al.
Publicado: (2017) -
Development of Respiratory Syncytial Virus Vaccine Candidates for the Elderly
por: Blanco, Jorge C. G., et al.
Publicado: (2023) -
Potential Neurocognitive Symptoms Due to Respiratory Syncytial Virus Infection
por: Andrade, Catalina A., et al.
Publicado: (2021) -
Bacterial and Viral Coinfections with the Human Respiratory Syncytial Virus
por: Pacheco, Gaspar A., et al.
Publicado: (2021)